BIOGEN INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 224.9 USD | +2.21% |
|
+3.27% | -13.07% |
| May. 31 | Biogen: Brussels grants marketing authorization for Charcot disease | CF |
| May. 31 | Disaster averted |  |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Bearish |
| Resistance | 235.32 | 267.71 | 234.52 |
| Spread/Res. | -4.41% | -15.98% | -4.08% |
| Spread/Supp. | +5.35% | +18.07% | +15.72% |
| Support | 213.51 | 190.52 | 194.38 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- BIIB Stock
- Charts Biogen Inc.
